Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Immunotech Laboratories Inc    IMMB

IMMUNOTECH LABORATORIES INC (IMMB)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 02/08 05:33:27 pm
1.0E-6 USD   -99.00%
2009IMMUNOTECH LABO : Immunotech Completes Merger Acquisition
PR
 SummaryQuotesChartsNewsCompany 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
08/07/2017 08/18/2017 08/21/2017 11/08/2017 02/08/2018 Date
1.0E-6(c) 0.0001(c) 0(c) 0.0001(c) 1.0E-6(c) Last
10 739 727 100 000 15 120 000 24 725 Volume
+9900.00% -100.00% -99.00% Change
More quotes
Company
Immunotech Laboratories, Inc. is a drug development company.It engages in the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.The company was founded on April 11, 2000 and is headquartered in Glendale, CA. 
More about the company
Latest news on IMMUNOTECH LABORATORIES IN
02/28IMMUNOTECH LABORATORIES : Enters Negotiations to Engage a Quality Person (QP) fo..
AQ
01/04IMMUNOTECH LABORATORIES : Receives Invitation to the 2018 Asia-Pacific Precision..
AQ
2017IMMUNOTECH LABORATORIES : ECPO Year End Update and Announces Appointment of Dr. ..
AQ
2009IMMUNOTECH LABORAT : Immunotech Completes Merger Acquisition
PR
More news
Sector news : Bio Therapeutic Drugs
06/20GILEAD SCIENCES : GSK takes billion-dollar drug fight with Gilead to top AIDS me..
RE
06/20Roche to Buy Rest of Cancer Firm -- WSJ
DJ
06/20Latecomer Sanofi looks to catch next wave of cancer therapies
RE
06/19Alexion Uses FDA Priority-Review Voucher for Blood Disorder
DJ
06/19Roche to Pay $2.4 Billion for Full Control of Foundation Medicine -- 2nd Upda..
DJ
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
2016HERBALIFE : Never Again 
Chart IMMUNOTECH LABORATORIES IN
Duration : Period :
Immunotech Laboratories In Technical Analysis Chart | IMMB | US45254F2039 | 4-Traders
Managers
NameTitle
Harry H. Zhabilov Chairman, President & Chief Executive Officer
Valentin Ivanov Dimitrov Director
Billy Ray Head-Business & Development
Adam Samuel Tracy Legal Counsel
Sector and Competitors
1st jan.Capitalization (M$)
IMMUNOTECH LABORATORIES INC0.00%0
GILEAD SCIENCES-0.80%92 410
VERTEX PHARMACEUTICALS3.10%40 566
REGENERON PHARMACEUTICALS-11.70%35 172
GENMAB-3.97%9 557
SAREPTA THERAPEUTICS INC152.21%9 196